OurCrowd — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesIsrael, IL
Eran Eden(Co-founder and CEO)in
BoardOri Hadomi(Chairman of the Board of Directors)
Co-investorsDNA CapitalHorizons VenturesMetaplanetQualcomm VenturesUnion Tech VenturesWestern Technology Investment+4 more
Morphisec provides automated moving target defense technology that continuously changes and morphs a company's digital environment to prevent advanced cyber threats.
AI & Machine LearningCybersecurityEnterprise Software
Ron Reinfeld(CEO)in
Co-investors408 VenturesARC VENTURESDTCPEvolution Equity PartnersJerusalem Venture Partners (JVP)JVP+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








